Evidence map›Paper›PMID 36297638›Full record

ReviewPharmaceutics2022

Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization.

Srushti Tambe, Divya Jain, Sai Kishore Meruva, Gopinath Rongala, Abhishek Juluri, Girish Nihalani, Hemanth Kumar Mamidi, Pavan Kumar Nukala, Pradeep Kumar Bolla

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. From prediction to performance:International journal of pharmaceutics: X · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Srushti TambeDepartment of Pharmaceutical Science and Technology, Institute of Chemical Technology, Mumbai 400019, India.ORCID 0000-0003-4892-4889
Divya JainDepartment of Pharmaceutical Science and Technology, Institute of Chemical Technology, Mumbai 400019, India.ORCID 0000-0001-5326-4606
Sai Kishore MeruvaCollege of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
Gopinath RongalaVenatorx Pharmaceuticals, Inc., 74 E Swedesford Rd. Suite 100, Malvern, PA 19355, USA.
Abhishek JuluriDepartment of Pharmaceutics, The University of Mississippi, Oxford, MS 38677, USA.
Girish NihalaniTeva Pharmaceuticals USA, Weston, FL 33331, USA.
Hemanth Kumar MamidiCollege of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.ORCID 0000-0002-3095-576X
Pavan Kumar NukalaCollege of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.ORCID 0000-0001-7093-4886
Pradeep Kumar BollaDepartment of Biomedical Engineering, College of Engineering, The University of Texas at El Paso, 500 W. University Ave., El Paso, TX 79968, USA.ORCID 0000-0001-5049-3550

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amorphous solid dispersions (ASDs) are among the most popular and widely studied solubility enhancement techniques. Since their inception in the early 1960s, the formulation development of ASDs has undergone tremendous progress. For instance, the method of preparing ASDs evolved from solvent-based approaches to solvent-free methods such as hot melt extrusion and Kinetisol

Indexed as

3D printingamorphous solid dispersionscharacterizationglass transition temperaturehot melt extrusionKinetisol®lipidspill burdenpolymerspoorly soluble drugsrecrystallizationspray dryingsuper saturationsurfactants

Identifiers

PMID36297638
PMCPMC9609913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.